Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Marty R who wrote (3701)	11/14/2000 3:42:54 PM
From: Gary Mohilner	Read Replies (1) \| Respond to of 5665

A few poster's on R.B. have commented on the Annual Meeting, I'm sure we'll hear from some over here as well. From what I've seen it was quite positive. The offering will be completed this week. The company will have a TAP drug developed from Apoptosis's technology that targets all kinds of cancer in pre-clinical trials next year, it will be targeted against one or more specific cancer. There should be additional new partnerships, including a genomics partnership. The MTD has not been reached, so their will be at least one more dose escalation. The point is, a lot of good things are happening, Mitch is very upbeat, the Quiet Period will be over shortly and the website will be updated. I don't think it was a coincidence that the price moved up substantially just the meeting ended. Gary